The Johns Hopkins CAHN Therapeutic Core is staffed with members of Johns Hopkins Drug Discovery, seasoned experts in the field of drug discovery research with significant experience in the pharmaceutical sector. Our core was designed to complement the strength of academic research by bridging a gap between basic science and therapeutic application.
One of the major challenges encountered by academic institutions aiming to develop new therapeutics has been the lack of a truly dedicated drug discovery unit with expertise in a range of disciplines required for therapeutics development. To the best of our knowledge, a dedicated and experienced drug discovery unit is not integrated into any NeuroHIV center, making our core innovative and uniquely positions to drive new therapeutic development.
Dr. Barbara Slusher discusses the evolving role of drug discovery in academia. To illustrate, Dr. Slusher traces an example prodrug across the drug development process — from bench to bedside.
